Yaakov Stern, PhD
Professor of Clinical Neuropsychology
*Please verify insurance participation with the physician's office when making an appointment.
Cognitive Neuroscience Division - www.cogneurosci.org
Taub Institute - www.taubinstitute.org
The Gertrude H. Sergievsky Center - cpmcnet.columbia.edu/dept/sergievsky
Lucy G. Moses Center for Memory and Behavioral Disorders - http://cpmcnet.columbia.edu/dept/neurology/memory/
Clinical Neuropsychology Service - http://columbiaclinicalneuropsych.org/
» Recent Publications
Yaakov Stern, PhD, is a Professor of Clinical Neuropsychology in the Departments of Neurology, Psychiatry, and Psychology at Columbia University College of Physicians and Surgeons. Dr. Stern is the director of the Division of Cognitive Neuroscience in the Department of Neurology. In addition, Dr. Stern is an associate director of the Alzheimer's Disease Research Center, and directs a post-doctoral training program in Neuropsychology and Cognition in Aging.
Cognitive Reserve: I am interested in understanding why some individuals show more cognitive deficit than others given the same degree of brain pathology. My own research, and that of others in the field, has shown that aspects of life experience, such as educational or occupational attainment, can impart reserve against brain pathology, allowing some people to maintain function longer than others. Ongoing imaging studies are designed to explore how this "cognitive reserve" is implemented in the brain.
Cognitive Intervention in Normal Aging: In parallel studies, we are exploring potential non-pharmacologic interventions that might improve cognition or cognitive/functional outcomes in normal aging. These include aerobic exercise and experimental videogames.
Cognitive Aging: In a new study, we are trying to understand why some cognitive processes are more affected by aging then others. We are imaging individuals, from 20 through 80 years of age, with multiple modalities in order to investigate this issue.
Heterogeneity of Alzheimer's disease: I am conducting a study designed to explore individual differences in the rate of decline and in the manifestation of cognitive, behavioral, psychiatric, and neurologic features in patients with Alzheimer's disease. One aim of the study is to produce algorithms for the prediction of important disease endpoints in individual patients.